We used this system to compare neutrophil differentiation from CD34+ progenitors of healthy control (HC) and BTHS patients, recruited from the NHS National Barth Syndrome Service at Bristol Royal Hospital for Children. This evidence concerns the gene CD34 and Barth syndrome.